ALIMET® feed supplement, an 88 per cent active source of methionine, has become the liquid methionine source most frequently used by nutritionists around the world. In addition to proven performance, ALIMET delivers an organic acid effect, reduces nitrogen excretion and supports performance during heat stress.

Jeff Klopfenstein, Novus Methionine Business Unit President, noted: "The ALIMET unit has evolved enormously since we started, and is now called the Methionine Business Unit. We produced 12,000 metric tons in that first year, and today we can produce that in a matter of days. I credit our laser-like attention to reliability, quality and steadfast customer service through the years to our success today."

Serving the animal feed industry as one of the top liquid methionine suppliers has provided the platform for Novus to solidify its commitment to the poultry industry, as demonstrated in Atlanta this week during the International Production and Processing Expo (IPPE). Novus is featuring ALIMET®, MHA®, MINTREX® and CIBENZA® at Booth 1529, Hall A at the Georgia World Congress Center (GWCC).

"We are dedicated to our customers in the livestock and poultry industries. We have expanded our product portfolio and remain true to our ALIMET roots," commented Samson Li, Vice President Sales and Marketing for Novus. "As the global demand for protein has grown, so has the need for quality feed ingredients and supplements. Novus has grown and expanded worldwide with this growing demand."

"ALIMET® and MHA® work better in nutrition applications and that’s only part of why we’ve grown so fast," states Ed Galo, North America General Manager. "The poultry industry experiences better economic performance with our products, and we work with our customers closely to help them identify every advantage possible in this competitive environment."

Novus manufactures both dry and liquid methionine sources in the USA. MHA® is manufactured in Little Rock, Arkansas at the same facility that makes OMRI Listed MINTREX® chelated trace minerals. MINTREX® is also borne of Novus technology and features a chelated in a 2:1 bond with HMTBa for greater bioavailability and absorption.